|
HY-P80525-10uL
|
MedChemexpress LLC
|
14-3-3 eta Antibody (YA838)
|
|
|
|
|
HY-P80525-100uL
|
MedChemexpress LLC
|
14-3-3 eta Antibody (YA838)
|
|
|
|
|
HY-P80525-50uL
|
MedChemexpress LLC
|
14-3-3 eta Antibody (YA838)
|
|
|
|
|
HY-P80526-10uL
|
MedChemexpress LLC
|
4E BP1 Antibody
|
|
|
|
|
HY-P80526-100uL
|
MedChemexpress LLC
|
4E BP1 Antibody
|
|
|
|
|
HY-P80526-50uL
|
MedChemexpress LLC
|
4E BP1 Antibody
|
|
|
|
|
HY-P80440-10uL
|
MedChemexpress LLC
|
4-Oct Antibody
|
|
|
|
|
HY-P80440-100uL
|
MedChemexpress LLC
|
4-Oct Antibody
|
|
|
|
|
HY-P80440-50uL
|
MedChemexpress LLC
|
4-Oct Antibody
|
|
|
|
|
HY-P80001-10uL
|
MedChemexpress LLC
|
53BP1 Antibody
|
|
|
|
|
HY-P80001-100uL
|
MedChemexpress LLC
|
53BP1 Antibody
|
|
|
|
|
HY-P80001-50uL
|
MedChemexpress LLC
|
53BP1 Antibody
|
|
|
|
|
HY-P99276-1mg
|
MedChemexpress LLC
|
Abagovomab [CAS 792921-10-9]
|
|
Cancer-programmed cell death
|
|
|
HY-P99276-5mg
|
MedChemexpress LLC
|
Abagovomab [CAS 792921-10-9]
|
|
Cancer-programmed cell death
|
|
|
HY-P80527-10uL
|
MedChemexpress LLC
|
ABCB5 Antibody (YA836)
|
|
|
|
|
HY-P80527-100uL
|
MedChemexpress LLC
|
ABCB5 Antibody (YA836)
|
|
|
|
|
HY-P80527-50uL
|
MedChemexpress LLC
|
ABCB5 Antibody (YA836)
|
|
|
|
|
HY-P80002-10uL
|
MedChemexpress LLC
|
ABCG2 Antibody
|
|
|
|
|
HY-P80002-100uL
|
MedChemexpress LLC
|
ABCG2 Antibody
|
|
|
|
|
HY-P80002-50uL
|
MedChemexpress LLC
|
ABCG2 Antibody
|
|
|
|
|
HY-P9934-1mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9934-10mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9934-5mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P80003-10uL
|
MedChemexpress LLC
|
ACE2 Antibody
|
|
|
|
|
HY-P80003-100uL
|
MedChemexpress LLC
|
ACE2 Antibody
|
|
|
|
